Fig. 5: Associations between PRDX4 expression and immunogenomic features and pathway activities. | npj Precision Oncology

Fig. 5: Associations between PRDX4 expression and immunogenomic features and pathway activities.

From: Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer

Fig. 5

A The relationship between expression of PRDX4 and MSI and TMB score. B The relationship between the expression of PRDX4 and EMT and ECM degradation. C The relationship between the expression of PRDX4 and pyrimidine metabolism and purine metabolism. Abbreviations: PRDX4, peroxiredoxin 4; MSI, microsatellite instability; TMB, tumor mutational burden; EMT, epithelial–mesenchymal transition; ECM, extracellular matrix.

Back to article page